Abstract
ObjectivesThe objective is to develop a pragmatic framework, based on value-based healthcare principles, to monitor health outcomes per unit costs on an institutional level. Subsequently, we investigated the association between health outcomes and healthcare utilisation costs.DesignThis is a retrospective cohort study.SettingA teaching hospital in Rotterdam, The Netherlands.ParticipantsThe study was performed in two use cases. The bariatric population contained 856 patients of which 639 were diagnosed with morbid obesity body mass index (BMI) <45 and 217 were diagnosed with morbid obesity BMI ≥45. The breast cancer population contained 663 patients of which 455 received a lumpectomy and 208 a mastectomy.Primary and secondary outcome measuresThe quality cost indicator (QCI) was the primary measures and was defined asQCI = (resulting outcome * 100)/average total costs (per thousand Euros)where average total costs entail all healthcare utilisation costs with regard to the treatment of the primary diagnosis and follow-up care. Resulting outcome is the number of patients achieving textbook outcome (passing all health outcome indicators) divided by the total number of patients included in the care path.ResultsThe breast cancer and bariatric population had the highest resulting outcome values in 2020 Q4, 0.93 and 0.73, respectively. The average total costs of the bariatric population remained stable (avg, €8833.55, min €8494.32, max €9164.26). The breast cancer population showed higher variance in costs (avg, €12 735.31 min €12 188.83, max €13 695.58). QCI values of both populations showed similar variance (0.3 and 0.8). Failing health outcome indicators was significantly related to higher hospital-based costs of care in both populations (p <0.01).ConclusionsThe QCI framework is effective for monitoring changes in average total costs and relevant health outcomes on an institutional level. Health outcomes are associated with hospital-based costs of care.
Reference30 articles.
1. OECD/European Union . Health at a Glance: Europe 2022: State of Health in the EU Cycle. Paris: OECD Publishing, 2022.
2. Organization for Economic Co-operation and Development . Healthcare Quality Indicators from 2011 to 2020. Paris: Organization for Economic Co-operation and Development, 2021. Available: https://stats.oecd.org/Index.aspx?QueryId=51879
3. Social determinants of Multimorbidity patterns: a systematic review;Álvarez-Gálvez;Front Public Health,2023
4. Innovation in the pharmaceutical industry: New estimates of R&D costs
5. Neumann PJ , Ganiats TG , Russell LB , et al . Siegel: Cost-Effectiveness in Health and Medicine. 1st Edition. Oxford: Scholarship Online, 1996.